Fundz

GOA Therapeutics Appoints Scott Howell as Chief Commercial Officer

PRIVATENov 18, 2026
New to company · from Novartis“Former Novartis U.S. Chief Strategy Officer Scott Howell, MD, MBA, Joins GOA Therapeutics as Chief Commercial Officer”

Position

Chief Commercial Officer

Company

GOA Therapeutics Corporation

Scott Howell
DallasBiotechnologyHealth CareTherapeutics

Description

GOA Therapeutics Corporation has appointed Scott Howell, MD, MBA, as Chief Commercial Officer. Dr. Howell brings over 30 years of experience in the pharmaceutical industry and will lead the commercialization of their innovative drug candidate GOA26.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at GOA Therapeutics Corporation, and when

A new leader at GOA Therapeutics Corporation brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day GOA Therapeutics Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GOA Therapeutics Corporation, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GOA Therapeutics Corporation. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GOA Therapeutics Corporation

Location

Dallas, Texas, United States

About

GOA Therapeutics Corporation is a biotechnology company developing potential first-in-class drug candidates for significant unmet medical needs. Its lead program, GOA26, is in preclinical development for acute alcohol intoxication and poisoning. The therapy aims to provide rapid intervention to lower blood alcohol concentration and prevent life-threatening complications. GOA Therapeutics is committed to changing the status quo in the treatment of alcohol-related emergencies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GOA Therapeutics Corporation changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for GOA Therapeutics Corporation's next move

Learn about Strategic plan

GOA Therapeutics Corporation changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.